Retirement Planning Group (Kansas)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$261K Buy
1,710
+42
+3% +$6.44K 0.01% 425
2025
Q4
$230K Buy
+1,668
New +$218K 0.01% 387

Other funds holding NVS

Retirement Planning Group (Kansas)'s NVS Position: Q1 2026 in Review

Retirement Planning Group (Kansas) increased its Novartis (NVS) stake by 2.5% in Q1 2026, buying an estimated $6.44K and bringing the position to 1,710 shares worth $261K. The position accounts for 0.01% of the portfolio, ranked #425.

Retirement Planning Group (Kansas) first reported a position in NVS in Q4 2025 and has held it in 2 quarters since. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Retirement Planning Group (Kansas) held 1,710 shares of Novartis worth $261K as of Q1 2026.
  • Retirement Planning Group (Kansas) bought 42 Novartis shares in Q1 2026, an estimated $6.44K.
  • Novartis made up 0.01% of Retirement Planning Group (Kansas)'s portfolio in Q1 2026, its #425 holding.
  • Retirement Planning Group (Kansas) first reported a position in Novartis in Q4 2025 and has held it in 2 quarters since.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Retirement Planning Group (Kansas)'s 13F filing for Q1 2026, filed 4 May 2026.